Related Experiment Videos
Update: recommendations to prevent hepatitis B virus transmission--United States
Insights
The Advisory Committee on Immunization Practices (ACIP) expanded hepatitis B vaccination recommendations in 1997 to cover all unvaccinated children aged 0-18 years. This initiative aimed to increase access to the hepatitis B vaccine for children through the Vaccines for Children program.
Area of Science:
- Immunology
- Public Health
- Vaccinology
Background:
- Hepatitis B virus (HBV) infection poses a significant public health risk.
- Previous vaccination strategies targeted specific high-risk pediatric populations.
Purpose of the Study:
- To detail the expanded hepatitis B vaccination recommendations by the ACIP in October 1997.
- To outline the inclusion of all unvaccinated children aged 0-18 years in the vaccination program.
- To highlight the availability of hepatitis B vaccine through the Vaccines for Children (VFC) program.
Main Methods:
- The Advisory Committee on Immunization Practices (ACIP) reviewed and expanded existing vaccination guidelines.
- Recommendations were updated to encompass a broader age group of children (0-18 years).
- The Vaccines for Children (VFC) program was utilized to facilitate vaccine access.
Main Results:
- Hepatitis B vaccination recommendations were expanded to include all unvaccinated children aged 0-18 years.
- The hepatitis B vaccine became accessible through the VFC program for eligible children.
- Established vaccination priorities for infants and high-risk groups were maintained.
Conclusions:
- The expanded recommendations aimed to improve hepatitis B prevention in the pediatric population.
- Increased vaccine accessibility through the VFC program was a key component of the strategy.
- Continued focus on high-risk groups and universal childhood vaccination is crucial for controlling HBV infection.
Abstract:
In October 1997, the Advisory Committee on Immunization Practices (ACIP) expanded its hepatitis B vaccination recommendations to include all unvaccinated children aged 0-18 years and made hepatitis B vaccine available through the Vaccines for Children program (VFC) for persons aged 0-18 years who are eligible for VFC. ACIP priorities for hepatitis B vaccination of children remain unchanged and include all infants; children in populations at high risk for hepatitis B virus (HBV) infection (e.g., Alaska Natives, Pacific Islanders, and children who reside in households of first-generation immigrants from countries where HBV infection is moderately or highly endemic); previously unvaccinated children aged 11-12 years; and older adolescents and adults in defined risk groups.